News
Rethinking Emergency Innovation: Lessons from the Front Lines
written by
Miranda Schmalfuhs
In this Pharmaceutical Executive interview, Marcel Botha, CEO of 10XBeta, reflects on the U.S.'s fragmented response to public health crises, drawing from his experience leading the Spiro Wave ventilator project during COVID-19. Botha outlines critical shortcomings in emergency innovation—lack of pipelines, supply chain fragility, and regulatory uncertainty—and calls for stronger public-private partnerships, decentralized manufacturing, and advanced tech like AI and 3D printing to future-proof crisis response.
Watch the full interview: Pharmaceutical Executive – Marcel Botha on Emergency Innovation
About
https://www.pharmexec.com/
Pharmaceutical Executive® provides insights and stories behind successful commercial strategies, research and development (R&D), market access and more, to its audience of pharmaceutical executives. Our original print and digital content is produced by a team of fulltime, in-house writers and industry experts, which makes us stand out from the competition. We go beyond the 24-hour news cycle and provide in-depth analysis and the strategic context to help executives navigate the maze of policy and business challenges that face this changing industry.
ABOUT THE Author
Miranda Schmalfuhs
Social Media Editor
Miranda Schmalfuhs is the associate group social media editor of Pharmaceutical Executive, Pharmaceutical Commerce, and Applied Clinical Trials and can be reached at mschmalfuhs@mjhlifesciences.com.
